BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3763155)

  • 1. Primary acquired nasolacrimal duct obstruction. A clinicopathologic report and biopsy technique.
    Linberg JV; McCormick SA
    Ophthalmology; 1986 Aug; 93(8):1055-63. PubMed ID: 3763155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patients.
    Tucker N; Chow D; Stockl F; Codère F; Burnier M
    Ophthalmology; 1997 Nov; 104(11):1882-6. PubMed ID: 9373121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic study of lacrimal sac and nasal mucosa in 44 patients with complete acquired nasolacrimal duct obstruction.
    Mauriello JA; Palydowycz S; DeLuca J
    Ophthalmic Plast Reconstr Surg; 1992; 8(1):13-21. PubMed ID: 1554647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
    Lee-Wing MW; Ashenhurst ME
    Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.
    Ali MJ; Mishra DK; Bothra N
    Curr Eye Res; 2021 Aug; 46(8):1132-1136. PubMed ID: 33583297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consecutive microscopic anatomical characteristics of the lacrimal sac and nasolacrimal duct: cases with or without inflammation.
    Mito H; Takahashi Y; Nakano T; Asamoto K; Ikeda H; Kakizaki H
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5233-7. PubMed ID: 25082889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcanalicular laser dacryocystorhinostomy for acquired nasolacrimal duct obstruction: an audit of 104 patients.
    Mor JM; Matthaei M; Schrumpf H; Koch KR; Bölke E; Heindl LM
    Eur J Med Res; 2018 Nov; 23(1):58. PubMed ID: 30446006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
    Makselis A; Petroska D; Kadziauskiene A; Jaruseviciene R; Ruzgys A; Cimbalas A; Besusparis J; Asoklis RS
    BMC Ophthalmol; 2022 Jan; 22(1):12. PubMed ID: 34986808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal obstruction in the neonate secondary to nasolacrimal duct cysts.
    Lusk RP; Muntz HM
    Int J Pediatr Otorhinolaryngol; 1987 Oct; 13(3):315-22. PubMed ID: 3679686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of routine lacrimal sac biopsy during dacryocystorhinostomy: A comprehensive review of literature.
    Koturović Z; Knežević M; Rašić DM
    Bosn J Basic Med Sci; 2017 Feb; 17(1):1-8. PubMed ID: 27754826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic findings from lacrimal sac biopsy specimens obtained during dacryocystorhinostomy.
    Anderson NG; Wojno TH; Grossniklaus HE
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):173-6. PubMed ID: 12918549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasolacrimal duct obstruction: clinicopathologic analysis of 205 cases.
    Altan-Yaycioglu R; Canan H; Sizmaz S; Bal N; Pelit A; Akova YA
    Orbit; 2010 Oct; 29(5):254-8. PubMed ID: 20704489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasolacrimal duct obstruction caused by an oncocytoma.
    de Bree R; Scheeren RA; Kummer A; Tiwari RM
    Rhinology; 2002 Sep; 40(3):165-7. PubMed ID: 12357720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of nasolacrimal duct obstruction compatible with localized sarcoidosis.
    Vasquez RJ; Linberg JV; McCormick SA
    Ophthalmic Plast Reconstr Surg; 1988; 4(3):147-51. PubMed ID: 3154734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of neoplasia in patients with unilateral epiphora.
    Bewes T; Sacks R; Sacks PL; Chin D; Mrad N; Wilcsek G; Tumuluri K; Harvey R
    J Laryngol Otol; 2015 Jul; 129 Suppl 3():S53-7. PubMed ID: 26173845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of lacrimal magnetic resonance hydrography and lacrimal endoscopy examination in the diagnosis and treatment of lacrimal duct obstructive diseases].
    Xiang N; Liu R; Zhang SJ; Hu WK; Zhan XY; Luo B; Ai T
    Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):117-22. PubMed ID: 26906707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasolacrimal bone changes in diseases of the lacrimal drainage system.
    Hinton P; Hurwitz JJ; Cruickshank B
    Ophthalmic Surg; 1984 Jun; 15(6):516-21. PubMed ID: 6462612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinus histiocytosis involving the lacrimal sac and duct. A clinicopathologic case report.
    Dolman PJ; Harris GJ; Weiland LH
    Arch Ophthalmol; 1991 Nov; 109(11):1582-4. PubMed ID: 1755741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of primary acquired nasolacrimal duct obstruction.
    Kashkouli MB; Sadeghipour A; Kaghazkanani R; Bayat A; Pakdel F; Aghai GH
    Orbit; 2010 Feb; 29(1):11-5. PubMed ID: 20302403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
    Ali MJ
    Prog Retin Eye Res; 2023 Sep; 96():101193. PubMed ID: 37394093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.